Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.
By Christopher deFilippi, J. D. de Lemos, R. Christenson, J. Gottdiener, W. Kop, M. Zhan, S. Seliger. Journal of the American Medical Association (JAMA), 2010
753 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/35a1f9b101c02ddabe58e3876820cbf6e9a589a7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the ARIC Study (2011, background): “that account for follow-up time to assess improvement in risk classification.(16) Although no risk”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “of the hospitalizations were related to noncardiovascular causes (87-89).”
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Although several epidemiological studies have revealed an independent link between risk for incident HF and biomarkers such as natriuretic peptides (335,336), highly sensitive troponin (337), and measures of renal function such as creatinine, phosphorus, urinary albumin, or albumin-creatinine ratio ”
- Analytical characteristics of high-sensitivity cardiac troponin assays. (2012, neutral): “이 전에는 검사법의 분석민감도(검출한계) 한계 때문에 측정할 수 없 었던 건강인 참고집단 내에서 측정된 농도를 다룬[6, 7] 위험도-결 과 데이터가 이 데이터베이스에는 포함되어 있다[9].”